Zai Lab Ltd (ZLAB) stock
ZLABNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30471% above fair value
$24.60−1.44 (-5.53%)
Close on Nov 13, 2026Market cap $3.82BP/E –Yield –
Zai Lab profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Zai Lab's profit margin for the twelve months ending Sep 30, 2026 was -44.9%. For fiscal 2025 it was -38.1%, against -64.4% the year before. The highest annual figure on record is -38.1% in fiscal 2025.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -38.1% | +26.3 |
| FY2024 | Dec 31, 2024 | -64.4% | +61.0 |
| FY2023 | Dec 31, 2023 | -125.5% | +80.7 |
| FY2022 | Dec 31, 2022 | -206.1% | +282.0 |
| FY2021 | Dec 31, 2021 | -488.2% | +61.1 |
| FY2020 | Dec 31, 2020 | -549.3% | +953.0 |
| FY2019 | Dec 31, 2019 | -1502.3% | +106307.8 |
| FY2018 | Dec 31, 2018 | -107810.1% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -42.6% | −11.7 |
| Q2 FY2026 | Jun 30, 2026 | -47.8% | −10.8 |
| Q1 FY2026 | Mar 31, 2026 | -51.2% | −5.7 |
| Q4 FY2025 | Dec 31, 2025 | -39.5% | +35.4 |
| Q3 FY2025 | Sep 30, 2025 | -31.0% | +9.8 |
| Q2 FY2025 | Jun 30, 2025 | -37.0% | +42.8 |
| Q1 FY2025 | Mar 31, 2025 | -45.5% | +15.9 |
| Q4 FY2024 | Dec 31, 2024 | -74.9% | +70.1 |
| Q3 FY2024 | Sep 30, 2024 | -40.7% | +59.1 |
| Q2 FY2024 | Jun 30, 2024 | -79.9% | +95.7 |
| Q1 FY2024 | Mar 31, 2024 | -61.4% | +16.9 |
| Q4 FY2023 | Dec 31, 2023 | -145.0% | −46.3 |
| Q3 FY2023 | Sep 30, 2023 | -99.9% | +180.2 |
| Q2 FY2023 | Jun 30, 2023 | -175.6% | +110.8 |
| Q1 FY2023 | Mar 31, 2023 | -78.3% | +98.1 |
| Q4 FY2022 | Dec 31, 2022 | -98.7% | +383.1 |
| Q3 FY2022 | Sep 30, 2022 | -280.1% | −56.5 |
| Q2 FY2022 | Jun 30, 2022 | -286.3% | +155.9 |
| Q1 FY2022 | Mar 31, 2022 | -176.3% | +982.2 |
| Q4 FY2021 | Dec 31, 2021 | -481.8% | +25.3 |
| Q3 FY2021 | Sep 30, 2021 | -223.7% | +211.4 |
| Q2 FY2021 | Jun 30, 2021 | -442.2% | +291.1 |
| Q1 FY2021 | Mar 31, 2021 | -1158.6% | −574.6 |
| Q4 FY2020 | Dec 31, 2020 | -507.1% | +492.4 |
| Q3 FY2020 | Sep 30, 2020 | -435.1% | +893.6 |
| Q2 FY2020 | Jun 30, 2020 | -733.3% | – |
| Q1 FY2020 | Mar 31, 2020 | -583.9% | – |
| Q4 FY2019 | Dec 31, 2019 | -999.5% | – |
| Q3 FY2019 | Sep 30, 2019 | -1328.7% | – |
See a number that looks wrong?